Nano-x Imaging vs Inspiremd
Nano-x Imaging is the larger business, with $13.0m of revenue in fiscal 2025 against $9.0m for Inspiremd (1.5 times as much). Inspiremd grew faster (28.1% against 15.4%). Inspiremd kept more of each dollar of sales as profit: a net margin of -543.3% against -576.1%. Inspiremd carries less debt relative to equity (0.0% against 2.4%).
| Latest fiscal year | Nano-x ImagingNNOX, 2025 | InspiremdNSPR, 2025 |
|---|---|---|
| Revenue | $13.0m | $9.0m |
| Revenue growth | 15.4% | 28.1% |
| Net income | −$75.0m | −$48.8m |
| Operating margin | -600.8% | -552.6% |
| Net margin | -576.1% | -543.3% |
| Return on equity | -45.6% | -106.9% |
| Free cash flow | −$45.0m | −$36.8m |
| Cash | $49.2m | $8.9m |
| Total debt | $3.3m | $0 |
| Debt to equity | 2.4% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | 127 |
| Market value | $20.4m | $29.7m |
| Price vs our value range | — | — |
| Moat score | — | 18 (Weak) |
| Insider trades, 12 months | 10 buys, 2 sales | 18 buys, 12 sales |